首页> 外国专利> CLINICAL EFFECT OF PHARMACEUTICAL PRODUCTS USING COMMUNICATION TOOL INTEGRATED WITH COMPOUND OF SEVERAL PHARMACEUTICAL PRODUCTS

CLINICAL EFFECT OF PHARMACEUTICAL PRODUCTS USING COMMUNICATION TOOL INTEGRATED WITH COMPOUND OF SEVERAL PHARMACEUTICAL PRODUCTS

机译:使用沟通工具与多种药品化合物集成的药物产品的临床疗效

摘要

A method of treating a medical condition with a combination of substances, wherein one of the substances is adalimumab, in combination with a computer program configured for: providing a patient with sets of questions adapted to the combination, to adalimumab, and to the non-adalimumab substances, wherein at least one of the sets of questions is related to perceived and/or measured therapeutic effects; subjecting the answers to the sets of questions to functions, thereby generating patient specific feedback; and adjusting a dosage of at least one substance based at least in part on the patient-specific feedback.
机译:一种用物质组合治疗医疗条件的方法,其中其中一种物质是Adalimalab,与配置为:为患者提供适合于组合的问题,对Adalimalab的患者以及非阿巴罗单抗物质,其中至少一个问题组与感知和/或测量的治疗效果有关;使答案对函数进行答案,从而产生患者的特定反馈;并至少部分地基于患者特异性反馈来调节至少一种物质的剂量。

著录项

  • 公开/公告号US2021233624A1

    专利类型

  • 公开/公告日2021-07-29

    原文格式PDF

  • 申请/专利权人 INTELLECTUAL PROPERTY ENABLER STOCKHOLM AB;

    申请/专利号US202117301826

  • 发明设计人 JOHAN CEDERLUND;

    申请日2021-04-15

  • 分类号G16H10/20;G16Z99;G16H20/10;G16H70/40;

  • 国家 US

  • 入库时间 2022-08-24 20:13:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号